Wilton, Connecticut does not presently have a provider listed. Buprenorphine is the therapeutic additive in Suboxone that reduces opiate withdrawal symptoms. Suboxone has become a familiar and highly sought opioid replacement medication that restores a person’s functioning following a period of decline in active opioid addiction. Only authorized doctors are legally able to write prescriptions for buprenorphine/suboxone. If you are a local physician aiming to treat Wilton area residents, you may purchase a featured listing on this page insuring that your medical services will be found by prospective patients searching our website for quality opioid treatment.
Several organizations in Ohio recently hosted a town hall discussion on the opioid crisis still occurring there and across the country. News commentator, Eric Bolling, was a moderator of the event which was held at Cedarville University.
Eric and his wife, Adrienne, lost their 19 year old son in 2017 due to an accidental overdose with the powerful opioid, fentanyl.
This town hall discussion was designed to continue raising public awareness on the danger of opioid misuse and the continuing need for treatment and recovery support services to help families deal with this perpetual problem.
The Centers for Disease Control (CDC) report that there were 70,237 drug overdoses in 2017 with 47,600 involving opioids specifically. The article linked above states that the state of Ohio ranked 2nd in overdose deaths only behind West Virginia.
There is promising news in that more Americans are now being educated on opioid risks, and consequently are taking better precautions as well as actively accessing methadone & suboxone programs offering helpful medication-assistance and behavioral counseling. Saving lives and offering recovery are messages that are being heard.
In past decades, opioid addiction was skewed more heavily toward an older generation of adults. But today we have larger numbers of youth using opioids and experiencing addiction-related problems at earlier ages. Importantly, research has demonstrated conclusively that those who remain engaged in treatment for six months or more are much more likely to stabilize and to enjoy sustained success with recovery.
A recent Reuters Health article highlights the fact that many opioid-addicted youth are either not yet engaging in treatment or are exiting treatment too early. While more youth are being saved through the overdose reversal drug naloxone, a majority of addicted youth are still not receiving medicated-assisted treatments such as buprenorphine or methadone.
More work is necessary to open up treatment avenues for young adults across America, and to both educate & compel youth to seek MAT (medication-assisted treatment) as soon as possible.
The opioid addiction problem in America will not soon disappear. Drugs continue to find their way across the U.S. border through multiple avenues. Positive efforts are indeed bringing needed change, but the complexity and extent of opioid addiction in the U.S. will require a long-term, sustained commitment throughout the country. We must get the message out – especially to young people who may not fully grasp the power of addiction!